SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-21-001239
Filing Date
2021-02-12
Accepted
2021-02-12 08:08:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 UNITED THERAPEUTICS CORPORATION p21-0471sc13g.htm SC 13G 60662
  Complete submission text file 0000902664-21-001239.txt   62329
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Subject) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-57843 | Film No.: 21622915
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G